BRCA1 Counteracts Progesterone Action by Ubiquitination Leading to Progesterone Receptor Degradation and Epigenetic Silencing of Target Promoters
Veronica Calvo,Miguel Beato +1 more
Reads0
Chats0
TLDR
Through in vitro and in vivo assays, it is found that BRCA1/BARD1 may be the main E3 ubiquitin ligase responsible for ubiquitination and degradation of PR in the absence of hormone.Abstract:
Germ-line mutations in the BRCA1 gene increase the risk of breast cancer in women, but the precise mechanistic basis for this connection remains uncertain. One popular hypothesis to explain breast tissue specificity postulates a link between BRCA1 and the action of the ovarian hormones estrogen and progesterone. Given the relevance of progesterone for normal mammary development and breast cancer formation, we searched for a functional relationship between BRCA1 and progesterone receptor (PR) in the PR-positive breast cancer cell line T47D. Here, we report that BRCA1 inhibits the transcriptional activity of PR by at least 2 mechanisms involving the E3 ubiquitin ligase activity of BRCA1. First, BRCA1 has a direct effect on the cellular level of PR and, hence, on the extent of PR recruitment to target promoters through the promotion of its ligand-independent and -dependent degradation. Through in vitro and in vivo assays, we found that BRCA1/BARD1 may be the main E3 ubiquitin ligase responsible for ubiquitination and degradation of PR in the absence of hormone. Second, after hormone treatment of cells, the BRCA1/BARD1 complex is recruited via interaction with PR to the hormone-responsive regions of PR target genes, affecting local levels of monoubiquitinated histone H2A and contributing to epigenetic silencing of these promoters. The connections between BRCA1/BARD1 and PR activity suggested by our findings may help explain why host mutations in BRCA1 exert a tissue specificity in preferentially elevating the risk of breast cancer.read more
Citations
More filters
Journal ArticleDOI
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
Christopher A. Maxwell,Javier Benitez,Laia Gómez-Baldó,Ana Osorio,Núria Bonifaci,Ricardo Fernandez-Ramires,Sylvain V. Costes,Elisabet Guinó,Helen Chen,G Evans,Pooja Mohan,Isabel Catala,Anna Petit,Helena Aguilar,Alberto Villanueva,Alvaro Aytes,Jordi Serra-Musach,Gad Rennert,Flavio Lejbkowicz,Paolo Peterlongo,Siranoush Manoukian,Bernard Peissel,Carla B. Ripamonti,Bernardo Bonanni,Alessandra Viel,Anna Allavena,Loris Bernard,Paolo Radice,Eitan Friedman,Bella Kaufman,Yael Laitman,Maya Dubrovsky,Roni Milgrom,Anna Jakubowska,Cezary Cybulski,Bohdan Górski,Katarzyna Jaworska,Katarzyna Durda,Grzegorz Sukiennicki,Jan Lubinski,Yin Yao Shugart,Susan M. Domchek,Richard Letrero,Barbara L. Weber,Frans B. L. Hogervorst,Matti A. Rookus,J. Margriet Collée,Peter Devilee,Marjolijn J. L. Ligtenberg,Rob B. van der Luijt,Cora M. Aalfs,Quinten Waisfisz,Juul T. Wijnen,Cornelis E. P. van Roozendaal,Douglas F. Easton,Susan Peock,Margaret Cook,Clare Oliver,Debra Frost,Patricia Harrington,D. Gareth Evans,Fiona Lalloo,Rosalind A. Eeles,Louise Izatt,Carol Chu,Diana Eccles,Fiona Douglas,Carole Brewer,Heli Nevanlinna,Tuomas Heikkinen,Fergus J. Couch,Noralane M. Lindor,Xianshu Wang,Andrew K. Godwin,Maria A. Caligo,Grazia Lombardi,Niklas Loman,Per Karlsson,Hans Ehrencrona,Anna von Wachenfeldt,Rosa B. Barkardottir,Ute Hamann,Muhammad Usman Rashid,Adriana Lasa,Trinidad Caldés,Raquel Andrés,Michael Schmitt,Volker Assmann,Kristen N. Stevens,Kenneth Offit,Joao Curado,Hagen Tilgner,Roderic Guigó,Gemma Aiza,Joan Brunet,Joan Castellsague,Griselda Martrat,Ander Urruticoechea,Ignacio Blanco,Laima Tihomirova,David E. Goldgar,Saundra S. Buys,Esther M. John,Alexander Miron,Melissa C. Southey,Mary B. Daly,Rita K. Schmutzler,Barbara Wappenschmidt,Alfons Meindl,Norbert Arnold,Helmut Deissler,Raymonda Varon-Mateeva,Christian Sutter,Dieter Niederacher,Evgeny Imyamitov,Olga M. Sinilnikova,Dominique Stoppa-Lyonne,Sylvie Mazoyer,Carole Verny-Pierre,Laurent Castera,Antoine De Pauw,Yves-Jean Bignon,Nancy Uhrhammer,Jean-Philippe Peyrat,Philippe Vennin,Sandra Fert Ferrer,Marie-Agnès Collonge-Rame,Isabelle Mortemousque,Amanda B. Spurdle,Jonathan Beesley,Xiaoqing Chen,Sue Healey,Mary Helen Barcellos-Hoff,Marc Vidal,Stephen B. Gruber,Conxi Lázaro,Gabriel Capellá,Lesley McGuffog,Katherine L. Nathanson,Antonis C. Antoniou,Georgia Chenevix-Trench,Markus C. Fleisch,Victor Moreno,Miguel Angel Pujana +143 more
TL;DR: Cell biological analysis of the protein product suggests a function in regulating development of the mammary gland and genetic analysis identifies the HMMR gene as a modifier of the breast cancer risk associated with BRCA1 gene mutation.
Journal ArticleDOI
State of the evidence 2017: an update on the connection between breast cancer and the environment
TL;DR: Evidence from epidemiological studies, as well as a better understanding of mechanisms linking toxicants with development of breast cancer, all reinforce the conclusion that exposures to these substances – many of which are found in common, everyday products and byproducts – may lead to increased risk of developing breast cancer.
Journal ArticleDOI
Structure-function of the tumor suppressor BRCA1
TL;DR: This mini-review examines the structure-function relationships of the BRCA1 protein and the relevance to cancer progression.
Journal ArticleDOI
Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy
Wen Zhou,Joyce M. Slingerland +1 more
TL;DR: The elucidation of mechanisms whereby oestrogen drives both ERα transactivation and receptor proteolysis might have important therapeutic implications not only for breast cancer but also potentially for other hormone-regulated cancers.
Journal ArticleDOI
Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer.
Javier Sanchez Guerrero,Iván E. Alfaro,Francisco Gómez,Andrew Asher Protter,Sebastian Bernales +4 more
TL;DR: The effects of enzalutamide on AR signaling, AR‐dependent gene expression and cell apoptosis are investigated, including binding of androgens to AR, AR nuclear translocation and association of AR with DNA.
References
More filters
Journal ArticleDOI
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
TL;DR: A procedure for preparing extracts from nuclei of human tissue culture cells that directs accurate transcription initiation in vitro from class II promoters, including tRNA and Ad 2 VA, is developed.
Journal ArticleDOI
Linkage of early-onset familial breast cancer to chromosome 17q21
TL;DR: Ch Chromosome 17q21 appears to be the locale of a gene for inherited susceptibility to breast cancer in families with early-onset disease, and genetic analysis yields a lod score of 5.98 for linkage of breast cancer susceptibility to D17S74 in early-ONSet families and negative lod scores in familiesWith late-onsets disease.
Journal ArticleDOI
Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.
Philippe Kastner,Andrée Krust,Bernard Turcotte,U. Stropp,Laszlo Tora,Hinrich Gronemeyer,Pierre Chambon +6 more
TL;DR: Using the hPR gene 5′‐flanking sequences as promoter region in chimeric genes, it is shown that a functional promoter directs initiation of hPR mRNAs from the authentic start sites located at +1 and +15.
Journal ArticleDOI
Cancer Incidence in BRCA1 Mutation Carriers
TL;DR: In carriers of BRCA1 mutations, the overall increased risk of cancer at sites other than breast and ovary is small and is observed in women but generally not in men.
Journal ArticleDOI
Extraction, purification and analysis of histones.
TL;DR: Standard protocols for acid extraction and salt extraction of histone proteins from chromatin are presented; separation of extracted histones by reversed-phase HPLC; analysis of histones and their specific post-translational modification profiles by acid urea (AU) gel electrophoresis and the additional separation of non-canonical histone variants by triton AU(TAU) and 2D TAU electrophoreis.